Skip to content

Observational study to assess the outcome of purification system that aims to decrease the immunity in patients undergoing aortic surgery.

A Prospective observational study to evaluate the outcome of cytokine hemadsorption during aortic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047314
Enrollment
58
Registered
2022-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I712- Thoracic aortic aneurysm, withoutrupture

Interventions

None listed

Sponsors

Medanta The Medicity
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients above 18 years of age giving consent eligible for Elective aortic surgery under Cardiopulmonary Bypass.

Exclusion criteria

Exclusion criteria: Patients below 18 years of age Patient did not provide consent Emergency surgery patients Patients undergoing aortic dissection Infective Endocarditis Moribund patients expected to die Patients receiving chemotherapy, immunosuppressants and steroids

Design outcomes

Primary

MeasureTime frame
1. Intra and post operative hemodynamic stability as evidenced by relative difference of the vasopressor requirement. 2.Assessment of device related adverse events during study period.Timepoint: T1(Baseline) T2(2hours after Discontinuation of CPB) T3(24 hours after Discontinuation of CPB) T4(48 hours after Discontinuation of CPB) T5(15 days after Surgery)

Secondary

MeasureTime frame
Evaluation of IL-6,CRP,Procalcitonin,lactate levels. 2. Need and duration of renal replacement therapy. 3.Stroke/cerebrovascular accidents 4.low cardiac output: cardiac index2.0L/min/m2. 5.Duration of Mechanical Ventilation 6.30 day Mortality 7.Need for mechanical circulatory support (IABP/ECMO) 8.Multi organ dysfunction syndrome Timepoint: T1(Baseline) T2(2hours after Discontinuation of CPB) T3(24 hours after Discontinuation of CPB) T4(48 hours after Discontinuation of CPB) T5(15 days after Surgery)

Countries

India

Contacts

Public ContactDr Mandeep Singh

Medanta The Medicity

yatinmehta@hotmail.com01244141414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026